ProCE Banner Activity

Impact of GLP-1 Receptor Agonists on Weight Loss in People Living With HIV

Conference Coverage
Slideset

In this retrospective study, use of GLP-1 receptor agonists was associated with improvements in weight, BMI, and A1C in people living with HIV who are receiving antiretroviral therapy. 

Released: October 20, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare